Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,189 | 742 | 99.1% |
| Education | $109.22 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,774 | 94 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,615 | 73 | $0 (2024) |
| Novo Nordisk Inc | $1,294 | 82 | $0 (2024) |
| PFIZER INC. | $999.58 | 86 | $0 (2024) |
| ABBVIE INC. | $901.04 | 65 | $0 (2024) |
| Lilly USA, LLC | $843.44 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $688.42 | 48 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $508.62 | 40 | $0 (2022) |
| Astellas Pharma US Inc | $277.81 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $245.09 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,399 | 121 | AstraZeneca Pharmaceuticals LP ($504.09) |
| 2023 | $2,700 | 146 | GlaxoSmithKline, LLC. ($506.43) |
| 2022 | $2,085 | 118 | GlaxoSmithKline, LLC. ($410.81) |
| 2021 | $1,722 | 108 | AstraZeneca Pharmaceuticals LP ($314.72) |
| 2020 | $610.55 | 38 | GlaxoSmithKline, LLC. ($93.57) |
| 2019 | $1,062 | 81 | AstraZeneca Pharmaceuticals LP ($146.87) |
| 2018 | $541.04 | 40 | Novartis Pharmaceuticals Corporation ($115.80) |
| 2017 | $1,179 | 94 | Janssen Pharmaceuticals, Inc ($185.20) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes Care | ||||||
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: VACCINES | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,282 | 4,814 | $701,890 | $372,619 |
| 2022 | 20 | 1,251 | 4,051 | $590,428 | $309,342 |
| 2021 | 25 | 1,936 | 4,994 | $671,846 | $354,630 |
| 2020 | 21 | 1,540 | 5,232 | $781,878 | $392,065 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 182 | 1,348 | $275,190 | $128,557 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 864 | $138,240 | $74,441 | 53.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 85 | 915 | $128,100 | $73,663 | 57.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 373 | $27,975 | $16,305 | 58.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 130 | 130 | $19,500 | $15,763 | 80.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 41 | 173 | $18,165 | $9,596 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 150 | $16,515 | $8,724 | 52.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 48 | 52 | $13,000 | $6,994 | 53.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 51 | 202 | $11,110 | $6,973 | 62.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 77 | 77 | $6,930 | $5,762 | 83.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,800 | $5,346 | 92.2% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 17 | 132 | $7,260 | $4,166 | 57.4% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 65 | 65 | $7,770 | $3,730 | 48.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 50 | $4,000 | $2,398 | 59.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 81 | 81 | $3,645 | $2,327 | 63.8% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 26 | 37 | $5,325 | $2,031 | 38.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 38 | 46 | $4,600 | $1,681 | 36.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 17 | $2,550 | $1,481 | 58.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 17 | 19 | $1,425 | $770.45 | 54.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 23 | $1,725 | $680.51 | 39.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 22 | $2,210 | $670.26 | 30.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $855.00 | $559.55 | 65.4% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 158 | 1,140 | $233,700 | $115,169 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 818 | $130,880 | $69,883 | 53.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 85 | 577 | $80,780 | $39,848 | 49.3% |
About Dr. Patrick Gilhool, DO
Dr. Patrick Gilhool, DO is a Family Medicine healthcare provider based in Elizabethtown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902848948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Gilhool, DO has received a total of $12,298 in payments from pharmaceutical and medical device companies, with $2,399 received in 2024. These payments were reported across 746 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,189).
As a Medicare-enrolled provider, Gilhool has provided services to 6,009 Medicare beneficiaries, totaling 19,091 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Elizabethtown, PA
- Active Since 06/12/2006
- Last Updated 04/15/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902848948
Products in Payments
- FARXIGA (Drug) $976.09
- TRELEGY ELLIPTA (Drug) $865.72
- ELIQUIS (Drug) $624.05
- Ozempic (Drug) $623.50
- XARELTO (Drug) $598.58
- VRAYLAR (Drug) $365.11
- MOUNJARO (Drug) $352.27
- Rybelsus (Drug) $330.78
- QULIPTA (Drug) $300.22
- TRULICITY (Drug) $293.94
- LOKELMA (Drug) $288.16
- SOLIQUA 100/33 (Biological) $265.35
- UBRELVY (Drug) $262.95
- REXULTI (Drug) $248.36
- BREZTRI (Drug) $245.53
- ENTRESTO (Drug) $245.09
- Vascepa (Drug) $227.88
- GEMTESA (Drug) $208.05
- AIRSUPRA (Drug) $170.02
- PREVNAR 20 (Biological) $166.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Elizabethtown
Dr. Jahin Patel, Md, MD
Family Medicine — Payments: $7,229
Andrea Watson, Md, MD
Family Medicine — Payments: $6,192
Dr. Paul Gerard, M.d, M.D
Family Medicine — Payments: $6,185
Christopher Brabazon, Do, DO
Family Medicine — Payments: $3,187
Dr. Kelsey Pappas, Md, MD
Family Medicine — Payments: $3,170
Gregory Smith, M.d, M.D
Family Medicine — Payments: $2,838